Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11

References

Page 1

	Year	Citations
IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking Jennifer Dufour, Michelle Dziejman, Michael T. Liu, The Journal of Immunology	2002	1.1K
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine Scott G. Hansen, Julia C. Ford, Matthew S. Lewis, Nature VaccinationVaccine DevelopmentProfound Early ControlImmunologyVirology	2011	988
CXCR3 in T cell function Joanna R. Groom, Andrew D. Luster Experimental Cell Research Signal TransductionT Cell FunctionAdaptive Immune SystemT-regulatory CellImmunology	2011	976
Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 Katherine E. Cole, Christine A. Strick, Timothy Paradis, The Journal of Experimental Medicine InflammationCytokineActivated T CellsImmunologyImmune Regulation	1998	873
Mig and IP-10: CXC chemokines that target lymphocytes Joshua Μ. Farber Journal of Leukocyte Biology Clinical ImmunologyChemokine BiologyMurine MigImmunologyImmune Regulation	1997	793
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge Scott G. Hansen, Cassandra Vieville, Nathan Whizin, Nature Medicine Rhesus MonkeysHuman RetrovirusImmunologyAntiviral ResponseAutoimmunity	2009	669
Donor-Derived Ip-10 Initiates Development of Acute Allograft Rejection Wayne W. Hancock, Wei Gao, Vilmos Csizmadia, The Journal of Experimental Medicine Graft InjuryImmunologyImmunologic MechanismImmunotherapyInflammation	2001	375
Activation phenotype, rather than central– or effector–memory phenotype, predicts the recall efficacy of memory CD8+ T cells Hirokazu Hikono, Jacob E. Kohlmeier, Shiki Takamura, The Journal of Experimental Medicine	2007	316
DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma Catherine King, Myfanwy B. Spellerberg, Delin Zhu, Nature Medicine VaccinationSingle-chain FvImmunologyTumor ImmunityPathology	1998	294
Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells. P D Greenberg, D E Kern, Martin A. Cheever The Journal of Experimental Medicine Cell TherapyCytotoxic T CellsT-regulatory CellImmunologyImmunotherapy	1985	288

Page 1